These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26722267)

  • 1. Familial chordoma: A case report and review of the literature.
    Wang KE; Wu Z; Tian K; Wang L; Hao S; Zhang L; Zhang J
    Oncol Lett; 2015 Nov; 10(5):2937-2940. PubMed ID: 26722267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical findings in families with chordoma with and without T gene duplications and in patients with sporadic chordoma reported to the Surveillance, Epidemiology, and End Results program.
    Parry DM; McMaster ML; Liebsch NJ; Patronas NJ; Quezado MM; Zametkin D; Yang XR; Goldstein AM
    J Neurosurg; 2021 May; 134(5):1399-1408. PubMed ID: 32559743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of immunotherapy in treatment refractory chordomas: review of current evidence.
    Alexander AY; Dhawan S; Venteicher AS
    Front Surg; 2024; 11():1375567. PubMed ID: 38881706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chordoma].
    George B; Bresson D; Bouazza S; Froelich S; Mandonnet E; Hamdi S; Orabi M; Polivka M; Cazorla A; Adle-Biassette H; Guichard JP; Duet M; Gayat E; Vallée F; Canova CH; Riet F; Bolle S; Calugaru V; Dendale R; Mazeron JJ; Feuvret L; Boissier E; Vignot S; Puget S; Sainte-Rose C; Beccaria K
    Neurochirurgie; 2014 Jun; 60(3):63-140. PubMed ID: 24856008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From notochord formation to hereditary chordoma: the many roles of Brachyury.
    Nibu Y; José-Edwards DS; Di Gregorio A
    Biomed Res Int; 2013; 2013():826435. PubMed ID: 23662285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T gene isoform expression pattern is significantly different between chordomas and notochords.
    Wang K; Hu Q; Wang L; Chen W; Tian K; Cao C; Wu Z; Jia G; Zhang L; Zeng C; Zhang J
    Biochem Biophys Res Commun; 2015 Nov; 467(2):261-7. PubMed ID: 26435504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of brachyury expression in chordomas.
    Dridi M; Boutonnat J; Dumollard JM; Peoc'h M; Karpathiou G
    Ann Diagn Pathol; 2021 Aug; 53():151760. PubMed ID: 33989961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chordoma: Immunohistochemical Analysis of Brachury.
    Sun HI; Guduk M; Gucyetmez B; Yapicier O; Pamir MN
    Turk Neurosurg; 2018; 28(2):174-178. PubMed ID: 28094431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chordoma: Genetics and Contemporary Management.
    Desai R; Pelargos PE; Dunn IF
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic features of four rare types of chordomas, confirmed by brachyury immunostaining.
    Rekhi B; Banerjee D; Ramadwar M; Bajpai J; Jambhekar NA
    Indian J Pathol Microbiol; 2017; 60(3):350-354. PubMed ID: 28937370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel therapeutic targets in chordoma.
    Bydon M; Papadimitriou K; Witham T; Wolinsky JP; Bydon A; Sciubba D; Gokaslan Z
    Expert Opin Ther Targets; 2012 Nov; 16(11):1139-43. PubMed ID: 22860993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skull base chordomas review of current treatment paradigms.
    Yaniv D; Soudry E; Strenov Y; Cohen MA; Mizrachi A
    World J Otorhinolaryngol Head Neck Surg; 2020 Jun; 6(2):125-131. PubMed ID: 32596658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chordoma: the entity.
    Yakkioui Y; van Overbeeke JJ; Santegoeds R; van Engeland M; Temel Y
    Biochim Biophys Acta; 2014 Dec; 1846(2):655-69. PubMed ID: 25193090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chordomas of the skull base: follow-up review and prognostic factors.
    Colli BO; Al-Mefty O
    Neurosurg Focus; 2001 Mar; 10(3):E1. PubMed ID: 16734401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling molecular advancements in chordoma tumorigenesis and treatment response: a review of scientific discoveries and clinical implications.
    Jin MC; Connolly ID; Ravi K; Tobert DG; MacDonald SM; Shin JH
    Neurosurg Focus; 2024 May; 56(5):E18. PubMed ID: 38691860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis.
    Kitamura Y; Sasaki H; Kimura T; Miwa T; Takahashi S; Kawase T; Yoshida K
    J Neuropathol Exp Neurol; 2013 Sep; 72(9):816-23. PubMed ID: 23965741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of VEGF receptors expression on the tumor cells in skull base chordoma.
    Morimoto Y; Tamura R; Ohara K; Kosugi K; Oishi Y; Kuranari Y; Yoshida K; Toda M
    J Neurooncol; 2019 Aug; 144(1):65-77. PubMed ID: 31240525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chordoma: the nonsarcoma primary bone tumor.
    Chugh R; Tawbi H; Lucas DR; Biermann JS; Schuetze SM; Baker LH
    Oncologist; 2007 Nov; 12(11):1344-50. PubMed ID: 18055855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis.
    Bohman LE; Koch M; Bailey RL; Alonso-Basanta M; Lee JY
    World Neurosurg; 2014 Nov; 82(5):806-14. PubMed ID: 25009165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chordoma arising from cranial base extending to oropharynx: an unusual presentation.
    Vasudevan V; Manjunath V; Devaraju D; Murali R
    J Maxillofac Oral Surg; 2015 Mar; 14(Suppl 1):103-7. PubMed ID: 25838681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.